Prescribers and patients would still need to identify the dispensing pharmacy and understand the preparation
Extending any step by two, four, or even eight additional weeks is always preferable to escalating through symptoms
Versus sulphonylureas (such as gliclazide), GLP-1 receptor agonists offer comparable glucose-lowering efficacy but with significantly lower hypoglycaemia risk and the advantage of weight loss rather than weight gain
These changes reduce the risk of metabolic syndrome, characterized by abdominal obesity, hypertension, insulin resistance, and dyslipidemia
That said, if constipation becomes severe or is significantly affecting your quality of life, don't hesitate to discuss it with your healthcare provider, as dose adjustments may help